Use of Ledipasvir/Sofosbuvir with or without Ribavirin in Patients Post-Liver Transplant: Evaluation of Real-World Datasets

被引：0
|
作者：
Flamm, S. [1 ]
Charlton, M. [2 ]
Manns, M. [3 ]
Prieto, M. [4 ]
Fernandez, I. [5 ]
Londono, M. [6 ]
Kwok, R. [7 ]
Smith, C. [8 ]
Lee, S. [9 ]
Ngo, H. [9 ]
Osinusi, A. [9 ]
Copans, A. [9 ]
Rossaro, L. [9 ]
Shoreibah, M. [10 ]
Massoud, O. [10 ]
Curry, M. [11 ]
Bourliere, M. [12 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
[2] Intermt Med Ctr, Murray, KY USA
[3] Hannover Med Sch, Hannover, Germany
[4] Hosp Univ I Politecn La Fe, Valencia, Spain
[5] Hosp Univ 12 Octubre, Madrid, Spain
[6] Hosp Clin Barcelona, Serv Hepatol, Barcelona, Spain
[7] Walter Reed Natl Mil Med Ctr, Washington, DC USA
[8] Medstar Georgetown Univ Hosp, Georgetown, Guyana
[9] Gilead Sci Inc, Foster City, CA USA
[10] Univ Alabama Birmingham, Birmingham, AL USA
[11] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[12] Hosp St Joseph, Marsielle, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
145
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [1] Retrospective Cohort Study: Ledipasvir-Sofosbuvir With/Without Ribavirin for Chronic Hepatitis C Post-Liver Transplant in a Real-World Population
    Hawkins, Kelsey L.
    Hot, Ives
    JOURNAL OF PHARMACY TECHNOLOGY, 2018, 34 (05) : 199 - 203
  • [2] Use of Ledipasvir/Sofosbuvir (LDV/SOF) with or without Ribavirin (RBV) in Genotype 1 (GT 1) HCV-infected Patients Post Liver Transplant (LT): Evaluation of Several Real-world Datasets (RWD)
    Bourliere, Marc
    Charlton, Michael R.
    Manns, Michael P.
    Prieto, Martin
    Fernandez, Inmaculada
    Londono, Maria-Carlota
    Kwok, Ryan M.
    Smith, Coleman
    Lee, Stacey
    Zhang, Jie
    Arterburn, Sarah
    Osinusi, Anu O.
    Le, Hadley
    Copans, Amanda
    Rossaro, Lorenzo
    Curry, Michael P.
    Flamm, Steven L.
    HEPATOLOGY, 2016, 64 : 963A - 964A
  • [3] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Mohamed Shoreibah
    Jordan Orr
    DeAnn Jones
    Jie Zhang
    Krishna Venkata
    Omar Massoud
    Hepatology International, 2017, 11 : 434 - 439
  • [4] Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease
    Herzer, Kerstin
    Welzel, Tania M.
    Spengler, Ulrich
    Hinrichsen, Holger
    Klinker, Hartwig
    Berg, Thomas
    Ferenci, Peter
    Peck-Radosavljevic, Markus
    Inderson, Akin
    Zhao, Yue
    Jimenez-Exposito, Maria Jesus
    Zeuzem, Stefan
    TRANSPLANT INTERNATIONAL, 2017, 30 (03) : 243 - 255
  • [5] Ledipasvir/sofosbuvir without ribavirin is effective in the treatment of recurrent hepatitis C virus infection post-liver transplant
    Shoreibah, Mohamed
    Orr, Jordan
    Jones, DeAnn
    Zhang, Jie
    Venkata, Krishna
    Massoud, Omar
    HEPATOLOGY INTERNATIONAL, 2017, 11 (05) : 434 - 439
  • [6] LEDIPASVIR/SOFOSBUVIR ± RIBAVIRIN IN HCV POST-TRANSPLANT PATIENTS: REAL-WORLD HETEROGENEOUS POPULATION FROM THE TRIO NETWORK
    Flamm, S.
    Bacon, B.
    Curry, M.
    Dieterich, D.
    Guest, L.
    Kowdley, K.
    Lee, Y.
    Tsai, N.
    Younossi, Z.
    Afdhal, N.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S822 - S823
  • [7] Ledipasvir/Sofosbuvir plus /-Ribavirin in HCV Post-Transplant Patients: Real-World Heterogeneous Population from the TRIO Network
    Curry, Michael P.
    Bacon, Bruce
    Dieterich, Douglas T.
    Guest, Lauren
    Kowdley, Kris
    Lee, Yoori
    Tsai, Naoky
    Younossi, Zobair
    Flamm, Steven L.
    TRANSPLANTATION, 2016, 100 : S91 - S91
  • [8] Treatment of Hepatitis C with ledipasvir, sofosbuvir with or without ribavirin in post liver transplant patients in an academic center
    Pyrsopoulos, Nikolaos
    Lingiah, Vivek A.
    Sanaka, Sirish
    Fung, Phoenix
    Punnoose, Merlin
    HEPATOLOGY, 2016, 64 : 810A - 810A
  • [9] The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data
    Pyrsopoulos, Nikolaos
    Trilianos, Panagiotis
    Lingiah, Vivek A.
    Fung, Phoenix
    Punnoose, Merlin
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2018, 30 (07) : 761 - 765
  • [10] Real-world experience with sofosbuvir/ribavirin and sofosbuvir-ledipasvir in HIV/HCV-coinfected patients
    McAneny, A.
    Dingwall, S.
    Ramgopal, M.
    Bagwell, D.
    Pierone, G., Jr.
    ANTIVIRAL THERAPY, 2015, 20 : A66 - A67
12345